Backlash to Report on CRISPR/Cas9 Editing of Human Germlines | GenomeWeb

Scientists are reacting to news that Chinese researchers have conducted germline gene editing on humans by calling the work immoral and premature and saying the technology remains far from useful for clinical applications for human germlines.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.